SCHEMBL5198230

SCHEMBL5198230

CC(C)(C)[Si](C)(C)OCCS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLCG1 P19174 1/20 0.44
KMT2A Q03164 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
DUT P33316 1/20 0.38
POLB P06746 7/20 0.38
LMNA P02545 4/20 0.38
GRK2 P25098 4/20 0.38
RECQL P46063 3/20 0.38
PTPN7 P35236 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
MAPK1 P28482 1/20 0.38
LOX P28300 1/20 0.37
KDM4E B2RXH2 2/20 0.37
PPARG P37231 1/20 0.37
NR2E3 Q9Y5X4 1/20 0.37
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409408 0.91 PLCG1 (0.42) PLCG1KMT2ATDP1CYP1A2CYP3A4
SCHEMBL30228760 0.80 CA1 (0.39) KMT2ADUTKDM4ECA12CA1
SCHEMBL2415090 0.77 SIGMAR1 (0.47) TDP1LMNAKDM4ETHRBALDH1A1
SCHEMBL13254524 0.76 PSIP1 (0.42) KMT2ACYP3A4CYP2C9CYP2C19DUT
SCHEMBL1939147 0.75 PLCG1 (0.55) PLCG1KMT2ATDP1POLBLMNA
SCHEMBL4243800 0.75 PLCG1 (0.59) PLCG1KMT2ATDP1POLBLMNA
SCHEMBL12395396 0.74 LMNA (0.42) TDP1POLBLMNACA12CA1
SCHEMBL861826 0.73 KMT2A (0.48) KMT2ALMNACA1CA2MEN1
SCHEMBL410888 0.73 DUT (0.40) DUTMAPK1KDM4EALDH1A1
SCHEMBL1941565 0.72 GAA (0.56) PLCG1KMT2ATDP1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 PLCG1 3956/4885KMT2A 1587/4885TDP1 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.